Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V., a foreign private issuer, was submitted on November 7, 2019. The report incorporates by reference the company's Unaudited Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the three and nine months ended September 30, 2019.
Key Financial Metrics
The specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not contained within the cover page text of this filing. These figures are located in the incorporated exhibits (Exhibit 99.1 and 99.2) which are referenced but not detailed in the provided source text.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance or operational status compared to prior periods. Such analysis is contained within the incorporated Management's Discussion and Analysis (Exhibit 99.2).
Guidance, Outlook, and Risks
This filing incorporates two press releases (Exhibits 99.3 and 99.4) dated November 7, 2019, and November 6, 2019, respectively. While these documents likely contain management commentary, outlook, or risk factors, the specific content of these releases is not included in the provided text. The filing notes that Exhibits 99.3 and 99.4 are not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific financial results for the three and nine months ended September 30, 2019.
- Examine Exhibit 99.2 for management's analysis of financial condition and results of operations.
- Read the press releases in Exhibits 99.3 and 99.4 for recent corporate announcements or strategic updates.
- Verify the incorporation by reference into the Form S-8 (No. 333-221656) and Form F-3 (No. 333-230560) registration statements.